Investing.com -- Glaukos Corporation (NYSE:GKOS)周三公布的第二季度业绩好于预期,但股价下跌2.3%,因投资者似乎对公司全年指引表示担忧。 这家眼科制药和医疗技术公司第二季度调整后每股亏损-$0.24,好于分析师预估的-$0.26。营收同比增长30%至$1.241亿,显著超过市场共识预期的$1.1552亿。公司的青光眼业务创下创纪录的$1.035亿...
Source LinkInvesting.com -- Glaukos Corporation (NYSE:GKOS)周三公布的第二季度业绩好于预期,但股价下跌2.3%,因投资者似乎对公司全年指引表示担忧。 这家眼科制药和医疗技术公司第二季度调整后每股亏损-$0.24,好于分析师预估的-$0.26。营收同比增长30%至$1.241亿,显著超过市场共识预期的$1.1552亿。公司的青光眼业务创下创纪录的$1.035亿...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.